Erektile Dysfunktion bei Depressionen und antidepressiver Therapie - derzeitige Therapieoptionen

Zusammenfassung

Die erektile Dysfunktion (ED) ist eine weitverbreitete und schambehaftete Störung. Sie kann als Symptom einer Depression oder als unerwünschte Wirkung antidepressiver Medikation auftreten. ED führt häufig zum Therapieabbruch insbesondere in der Rezidivprophylaxe. Mit den Phosphodiesterasehemmern wie Sildenafil, Tadalafil und Vardenafil können erektile Dysfunktionen multipler Genese erfolgreich behandelt werden. Durch den komplementären Einsatz in der Psychiatrie kann eine Verbesserung bei der Behandlung bestimmter Depressionsformen erzielt werden. Außerdem kann sich dadurch die Compliance medikamentöser antidepressiver Therapien erhöhen.

Abstract

Erectile dysfunction (ED) is a common problem in the general population, but also a symptom of both treated and untreated depression. As a side effect of antidepressant medication, erectile dysfunction appears to be one of the principal reasons for discontinuing antidepressant treatment. Avoiding or switching antidepressants is problematic, as this may lead to an increase in depressive symptoms. Our review shows that oral phosphodiesterase inhibitors are an option in treating both ED resulting from depression and from antidepressant medication.

Literatur

• 1 Bauer M, Whybrow P C, Angst J. et al . World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder.  World J Biol Psychiatry. 2002;  3 5-43
• 2 Nurnberg H G, Hensley P L. Sildenafil citrate for the management of antidepressant-associated erectile dysfunction.  J Clin Psychiatry. 2003;  64 (Suppl 10) 20-25
• 3 NIH Consensus Conference . Impotence. NIH Consensus Development Panel on Impotence.  JAMA. 1993;  270 83-90
• 4 Derouet H, Osterhage J, Sittinger H. Erektile Funktionsstörungen - Epidemiologie, Physiologie, Ätiologie, Diagnostik und Therapie.  Nervenarzt. 2004;  75 595-605
• 5 Fazio L, Brock G. Erectile dysfunction: management update.  CMAJ. 2004;  170 1429-1437
• 6 Mann K, Pankok J, Connemann B. et al . Sleep investigations in erectile dysfunction.  J Psychiatr Res. 2005;  39 93-99
• 7 Seidman S N. Exploring the relationship between depression and erectile dysfunction in aging men.  J Clin Psychiatry. 2002;  63 (Suppl 5) 5-12
• 8 Araujo A B, Durante R, Feldman H A. et al . The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study.  Psychosom Med. 1998;  60 458-465
• 9 Araujo A B, Johannes C B, Feldman H A. et al . Relation between psychosocial risk factors and incident erectile dysfunction: prospective results from the Massachusetts Male Aging Study.  Am J Epidemiol. 2000;  152 533-541
• 10 Rosen R C, Marin H. Prevalence of antidepressant-associated erectile dysfunction.  J Clin Psychiatry. 2003;  64 (Suppl 10) 5-10
• 11 Braun M, Wassmer G, Klotz T. et al . Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’.  Int J Impot Res. 2000;  12 305-311
• 12 Schäfer G A, Englert H S, Ahlers C J. et al . Erektionsstörung und Lebensqualität - Erste Ergebnisse der Berliner Männer-Studie.  Sexuologie. 2003;  10 50-60
• 13 Nicolosi A, Moreira Jr E D, Shirai M. et al . Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction.  Urology. 2003;  61 201-206
• 14 Shabsigh R, Klein L T, Seidman S. et al . Increased incidence of depressive symptoms in men with erectile dysfunction.  Urology. 1998;  52 848-852
• 15 Steiger A, Holsboer F, Benkert O. Studies of nocturnal penile tumescence and sleep electroencephalogram in patients with major depression and in normal controls.  Acta Psychiatr Scand. 1993;  87 358-363
• 16 Nicolosi A, Moreira Jr E D, Villa M. et al . A population study of the association between sexual function, sexual satisfaction and depressive symptoms in men.  J Affect Disord. 2004;  82 235-243
• 17 Kantor J, Bilker W B, Glasser D B. et al . Prevalence of erectile dysfunction and active depression: an analytic cross-sectional study of general medical patients.  Am J Epidemiol. 2002;  156 1035-1042
• 18 Souverein P C, Egberts A C, Sturkenboom M C. et al . The Dutch cohort of sildenafil users: baseline characteristics.  BJU Int. 2001;  87 648-653
• 19 Rosen R C, Lane R M, Menza M. Effects of SSRIs on sexual function: a critical review.  J Clin Psychopharmacol. 1999;  19 67-85
• 20 Ekselius L, Knorring L von. Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care.  J Clin Psychopharmacol. 2001;  21 154-160
• 21 Kennedy S H, Eisfeld B S, Dickens S E. et al . Antidepressant-Induced Sexual Dysfunction During Treatment With Moclobemide, Paroxetine, Sertraline, and Venlafaxine.  J Clin Psychiatry. 2000;  61 276-281
• 22 Montejo-Gonzalez A L, Llorca G, Izquierdo J A. et al . SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.  J Sex Marital Ther. 1997;  23 176-194
• 23 Philipp M, Tiller J W, Baier D. et al . Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.  Eur Neuropsychopharmacol. 2000;  10 305-314
• 24 Fink H A, MacDonald R, Rutks I R. et al . Trazodone for erectile dysfunction: a systematic review and meta-analysis.  BJU Int. 2003;  92 441-446
• 25 Nurnberg H G, Seidman S N, Gelenberg A J. et al . Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression.  Urology. 2002;  60 58-66
• 26 Goldstein I, Lue T F, Padma-Nathan H. et al . Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.  N Engl J Med. 1998;  338 1397-1404
• 27 Seidman S N, Roose S P, Menza M A. et al . Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate.  Am J Psychiatry. 2001;  158 1623-1630
• 28 Muller M J, Benkert O. Lower self-reported depression in patients with erectile dysfunction after treatment with sildenafil.  J Affect Disord. 2001;  66 255-261
• 29 Tignol J, Furlan P M, Gomez-Beneyto M. et al . Efficacy of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in remission from depression.  Int Clin Psychopharmacol. 2004;  19 191-199
• 30 Milman H A, Arnold S B. Neurologic, psychological, and aggressive disturbances with sildenafil.  Ann Pharmacother. 2002;  36 1129-1134
• 31 Schultheiss D, Muller S V, Nager W. et al . Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials.  World J Urol. 2001;  19 46-50
• 32 Grass H, Klotz T, Fathian-Sabet B. et al . Sildenafil (Viagra): is there an influence on psychological performance?.  Int Urol Nephrol. 2001;  32 409-412
• 33 Arnavaz A, Aurich A, Weissenborn K. et al . Effect of sildenafil (Viagra) on cerebral blood flow velocity: a pilot study.  Psychiatry Res. 2003;  122 207-209
• 34 Kruuse C, Thomsen L L, Jacobsen T B. et al . The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects.  J Cereb Blood Flow Metab. 2002;  22 1124-1131
• 35 Morales A, Gingell C, Collins M. et al . Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction.  Int J Impot Res. 1998;  10 69-73
• 36 Labbate L A, Croft H A, Oleshansky M A. Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation.  J Clin Psychiatry. 2003;  64 (Suppl 10) 11-19
• 37 Montejo A L, Llorca G, Izquierdo J A. et al . Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.  J Clin Psychiatry. 2001;  62 (Suppl 3) 10-21
• 38 Fava M, Rankin M. Sexual functioning and SSRIs.  J Clin Psychiatry. 2002;  63 (Suppl 5) 13-16
• 39 Kang B J, Lee S J, Kim M D. et al . A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction.  Hum Psychopharmacol. 2002;  17 279-284
• 40 Nelson E B, Shah V N, Welge J A. et al . A placebo-controlled, crossover trial of granisetron in SRI-induced sexual dysfunction.  J Clin Psychiatry. 2001;  62 469-473
• 41 Masand P S, Ashton A K, Gupta S. et al . Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study.  Am J Psychiatry. 2001;  158 805-807
• 42 Nurnberg H G, Gelenberg A, Hargreave T B. et al . Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors.  Am J Psychiatry. 2001;  158 1926-1928
• 43 Nurnberg H G, Hensley P L, Gelenberg A J. et al . Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial.  JAMA. 2003;  289 56-64
• 44 Nurnberg H G, Duttagupta S. Economic analysis of sildenafil citrate (Viagra) add-on to treat erectile dysfunction associated with selective serotonin reuptake inhibitor use.  Am J Ther. 2004;  11 9-12